Patient characteristics
| . | No. . | % . |
|---|---|---|
| Age, y | ||
| 60-64 | 22 | 37 |
| 65-69 | 25 | 42 |
| 70-75 | 13 | 22 |
| Sex | ||
| Female | 26 | 43 |
| Male | 34 | 57 |
| Histology | ||
| Lymphocyte predominant | 4 | 7 |
| Nodular sclerosis | 17 | 28 |
| Mixed cellularity | 29 | 48 |
| Classical HL, unspecified | 10 | 17 |
| Stage | ||
| IA | 1 | 2 |
| IB | 1 | 2 |
| IIA | 11 | 18 |
| IIB | 10 | 17 |
| IIIA | 8 | 13 |
| IIIB | 5 | 8 |
| IVA | 6 | 10 |
| IVB | 18 | 30 |
| Early unfavorable | 20 | 33 |
| Advanced | 40 | 67 |
| Risk factor | ||
| Large mediastinal mass | 3 | 5 |
| Extranodal involvement | 11 | 19 |
| 3 or more lymph node areas | 42 | 71 |
| Elevated ESR | 39 | 68 |
| . | No. . | % . |
|---|---|---|
| Age, y | ||
| 60-64 | 22 | 37 |
| 65-69 | 25 | 42 |
| 70-75 | 13 | 22 |
| Sex | ||
| Female | 26 | 43 |
| Male | 34 | 57 |
| Histology | ||
| Lymphocyte predominant | 4 | 7 |
| Nodular sclerosis | 17 | 28 |
| Mixed cellularity | 29 | 48 |
| Classical HL, unspecified | 10 | 17 |
| Stage | ||
| IA | 1 | 2 |
| IB | 1 | 2 |
| IIA | 11 | 18 |
| IIB | 10 | 17 |
| IIIA | 8 | 13 |
| IIIB | 5 | 8 |
| IVA | 6 | 10 |
| IVB | 18 | 30 |
| Early unfavorable | 20 | 33 |
| Advanced | 40 | 67 |
| Risk factor | ||
| Large mediastinal mass | 3 | 5 |
| Extranodal involvement | 11 | 19 |
| 3 or more lymph node areas | 42 | 71 |
| Elevated ESR | 39 | 68 |
HL indicates Hodgkin lymphoma; and ESR, erythrocyte sedimentation rate.